FCG Advisors »

Phathom Pharmaceuticals shares owned by FCG Advisors

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by FCG Advisors from 13F filings

Historical chart of FCG Advisors investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by FCG Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by FCG Advisors

Quarter filed Position value Share count Share price at filing
2020-09-30 $598k 16k 36.69
2020-06-30 $536k 16k 32.88
2020-03-31 $421k 16k 25.83

More positions owned by FCG Advisors

Bristol Myers Squibb (BMY)
Ishares Tr S&p 500 Grwt Etf Etf (IVW)
Vanguard Index Fds Extend Mkt Etf Etf (VXF)
Vanguard Tax-managed Ftse Dev Mkt Etf Etf (VEA)
Ishares Tr S&p 500 Val Etf Etf (IVE)
Spdr S&p 500 Etf Tr Tr Unit Etf (SPY)
Apple (AAPL)
Jp Morgan Exchange Traded Fd ultra shrt etf (JMST)
Invesco Exch Trd Slf Bulshs 2022 Cb Etf
Invesco Exch Trd Slf Bulshs 2021 Cb Etf
Johnson & Johnson (JNJ)
Microsoft Corporation (MSFT)
Invesco Exch Trd Slf Bulshs 2023 Cb Etf
Ishares Tr Select Divid Etf Etf (DVY)
Invesco Exch Trd Slf Bulshs 2020 Cb Etf

View all positions for FCG Advisors

Top funds holding Phathom Pharmaceuticals

Frazier Life Sciences Management
Medicxi Ventures Management
Carlyle
BlackRock
Ensign Peak Advisors
Vanguard Group
NEA Management Company
Avidity Partners Management
683 Capital Management
Jennison Associates
Gilder, Gagnon, Howe & Co
Propel Bio Management
Decheng Capital
Geode Capital Management
Kennedy Capital Management

View all funds holding Phathom Pharmaceuticals